Cargando…
Metformin therapy and cognitive dysfunction in patients with type 2 diabetes: A meta-analysis and systematic review
BACKGROUND: Type 2 diabetes (T2D) is a risk factor for cognitive dysfunction. The relationship between metformin therapy and cognitive function in patients with T2D is unknown. Therefore, we determined the relationship between metformin therapy and cognitive function in patients with T2D using a met...
Autores principales: | Zhang, Qing-Qing, Li, Wen-Shan, Liu, Zhou, Zhang, Hui-Li, Ba, Ying-Gui, Zhang, Rui-Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478804/ https://www.ncbi.nlm.nih.gov/pubmed/32150083 http://dx.doi.org/10.1097/MD.0000000000019378 |
Ejemplares similares
-
Efficacy and safety of liraglutide versus sitagliptin both in combination with metformin in patients with type 2 diabetes: A systematic review and meta-analysis
por: Li, Mingxing, et al.
Publicado: (2017) -
Efficacy and safety of metformin in the treatment of gestational diabetes: A protocol for systematic review and meta-analysis
por: Mao, Weirong, et al.
Publicado: (2021) -
Sitagliptin/Metformin Versus Insulin Glargine Combined With Metformin in Obese Subjects With Newly Diagnosed Type 2 Diabetes
por: Ji, Ming, et al.
Publicado: (2016) -
Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes: A meta-analysis
por: Zhuang, Yan, et al.
Publicado: (2020) -
Effect of dipeptidyl peptidase-4 inhibitors inhibitor on cognitive dysfunction in diabetes: A protocol for systematic review and meta analysis
por: Liu, Shiyu, et al.
Publicado: (2020)